Cronos (CRON) Income from Continuing Operations (2018 - 2026)
Cronos (CRON) posted quarterly Income from Continuing Operations of 15711000.0 for Q1 2026, up 103.43% year-over-year from 7723000.0 in Q1 2025, and up 3299.8% quarter-over-quarter from 491000.0 in Q4 2025.
Cronos (CRON) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Cronos' Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 15711000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 103.43% year-over-year to 15711000.0; the TTM figure through Mar 2026 stood at 5059000.0 (down 89.93% YoY), while the FY2025 annual figure was 2929000.0, down 107.32% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 15711000.0, up from 491000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 43941000.0 in Q4 2024, with the low at 76181000.0 in Q4 2022.
- The 5-year median for Income from Continuing Operations is 5663000.0 (2023), against an average of 10417705.88.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations soared 560.63% in 2024, then plunged 339.34% in 2025.
- Cronos' Income from Continuing Operations stood at 76181000.0 in 2022, then surged by 40.73% to 45151000.0 in 2023, then soared by 197.32% to 43941000.0 in 2024, then sank by 101.12% to 491000.0 in 2025, then jumped by 3299.8% to 15711000.0 in 2026.
- Business Quant data shows CRON's Income from Continuing Operations at 15711000.0 in Q1 2026, 491000.0 in Q4 2025, and 28321000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cronos | 1.23 Bn | 437.76 Mn | 28.45 Mn | 35.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.66 Mn |
| Mar 31, 2026 | 15.71 Mn |
| Dec 31, 2025 | -491,000.00 |
| Sep 30, 2025 | 28.32 Mn |
| Jun 30, 2025 | -38.48 Mn |
| Mar 31, 2025 | 7.72 Mn |
| Dec 31, 2024 | 43.94 Mn |
| Sep 30, 2024 | 7.32 Mn |
| Jun 30, 2024 | -8.76 Mn |
| Mar 31, 2024 | -2.48 Mn |
| Dec 31, 2023 | -45.15 Mn |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -5.66 Mn |
| Mar 31, 2023 | -18.04 Mn |
| Dec 31, 2022 | -76.18 Mn |
| Sep 30, 2022 | -33.11 Mn |
| Jun 30, 2022 | -17.53 Mn |
| Mar 31, 2022 | -32.65 Mn |
| Dec 31, 2021 | 134.73 Mn |
| Sep 30, 2021 | 77.58 Mn |